VREOF News and Press, Vireo Health International Inc From 10/29/25

CHICAGO and MINNEAPOLIS, Oct. 29, 2025 (GLOBE NEWSWIRE) -- Vireo Growth Inc. (“Vireo”) (CSE: VREO; OTCQX: VREOF) and Verano Holdings Corp. (“Verano”, Vireo and Verano, each a “Company”) (Cboe CA: VRNO) (OTCQX: VRNOF) today announced that they have reached...

– Parties enter into Restructuring Support Agreement; Vireo to bid to acquire control of Schwazze assets – – Schwazze operates 63 dispensaries and 10 manufacturing facilities in Colorado and New Mexico – MINNEAPOLIS, Oct. 14, 2025 (GLOBE NEWSWIRE) -- Vire...

MINNEAPOLIS, Oct. 02, 2025 (GLOBE NEWSWIRE) -- Vireo Growth Inc. ("Vireo" or the "Company") (CSE: VREO; OTCQX: VREOF) today announced that it has entered into definitive agreements to acquire approximately 86% of the outstanding senior secured convertible notes (the “Notes”) of publ...

– Company now dispensing adult-use cannabis at all eight Green Goods® dispensaries in Minnesota – – With a population of 5.7 million, adult-use launch expected to drive strong organic revenue growth – MINNEAPOLIS, Sept. 16, 2025 (GLOBE NEWSWIRE) -- V...

MINNEAPOLIS , Sept. 04, 2025 (GLOBE NEWSWIRE) -- Vireo Growth Inc. ("Vireo" or the "Company") (CSE: VREO; OTCQX: VREOF), at the request of the Canadian Investment Regulatory Organization (“CIRO”), today confirmed that Company management is unaware of any material change in the Compa...

2025-09-02 00:59:07 ET Introduction Since mid-year, the Twittersphere has been replete with comments that cannabis was about to be moved from a Schedule 1 to a Schedule 3 substance. Those comments gained increased credibility on August 11th when President Trump said his administrati...

2025-08-13 11:12:01 ET More on Vireo Growth Vireo Growth Inc. (VREOF) Q2 2025 Earnings Call Transcript Historical earnings data for Vireo Growth Financial information for Vireo Growth Read the full article on Seeking Alpha For further details see: ...

2025-08-13 11:11:07 ET Vireo Growth Inc. (VREOF) Q2 2025 Earnings Call August 13, 2025 08:30 A.M. ET Company Participants J. Tyson Macdonald - Chief Financial Officer John Michael Mazarakis - CEO & Co-Executive Chairman Conference Call Participants Pa...

2025-08-13 07:21:44 ET More on Vireo Growth Historical earnings data for Vireo Growth Financial information for Vireo Growth Read the full article on Seeking Alpha For further details see: Vireo Growth GAAP EPS of -$0.03, revenue of $48.06M beats by $23.03M

Western Uranium & Vanadium Corp (WSTRF) is expected to report for Q2 2025 IceCure Medical Ltd. (ICCM) is expected to report $-0.06 for Q2 2025 TFF Pharmaceuticals Inc - Ordinary Shares (TFFP) is expected to report for quarter end 2025-06-30 Scientific Industries, Inc. (SCND) is ex...